1-4 of 4
paroxysmal nocturnal hemoglobinuria
Close
Sort by
Journal Articles

The predictive value of PNH clones, 6p CN-LOH, and clonal TCR gene rearrangement for aplastic anemia diagnosis

Yash B. Shah, Salvatore F. Priore, Yimei Li, Chi N. Tang, Peter Nicholas, Peter Kurre, Timothy S. Olson, Daria V. Babushok
Journal: Blood Advances
Blood Adv (2021) 5 (16): 3216–3226.
https://doi.org/10.1182/bloodadvances.2021004201
Published: 2021
Includes: Supplemental data
Journal Articles

Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination

Clinical Trials & Observations
Andrew Jay Portuguese, Cassandra Sunga, Rebecca Kruse-Jarres, Terry Gernsheimer, Janis Abkowitz
Journal: Blood Advances
Blood Adv (2021) 5 (13): 2794–2798.
https://doi.org/10.1182/bloodadvances.2021004957
Published: 2021
Journal Articles

Ravulizumab (ALXN1210) in patients with paroxysmal nocturnal hemoglobinuria: results of 2 phase 1b/2 studies

Clinical Trials & Observations
Alexander Röth, Scott T. Rottinghaus, Anita Hill, Eric S. Bachman, Jin Seok Kim, Hubert Schrezenmeier, Louis Terriou, Álvaro Urbano-Ispizua, Richard A. Wells, Jun Ho Jang, Austin G. Kulasekararaj, Jeff Szer, Rasha Aguzzi, Andrew I. Damokosh, Lori Shafner, Jong Wook Lee
Journal: Blood Advances
Blood Adv (2018) 2 (17): 2176–2185.
https://doi.org/10.1182/bloodadvances.2018020644
Published: 2018
Includes: Supplemental data
Journal Articles

Potential impact of complement regulator deficiencies on hemolytic reactions due to minor ABO-mismatched transfusions

Clinical Trials & Observations
Priyanka Pandey, Waseem Q. Anani, Jerome L. Gottschall, Gregory A. Denomme
Journal: Blood Advances
Blood Adv (2017) 1 (23): 1977–1982.
https://doi.org/10.1182/bloodadvances.2017008805
Published: 2017